Description
Ancolase-1000 is a powerful antibiotic formulation containing Vancomycin Hydrochloride 1000 mg for Intravenous Infusion IP, designed to combat serious bacterial infections. Widely used in clinical settings, this injectable medication is particularly effective against gram-positive bacteria, including resistant strains such as MRSA (Methicillin-Resistant Staphylococcus aureus). Supplied in a convenient 1×20 ml vial, Ancolase-1000 ensures precise dosing and safe administration under medical supervision.
Vancomycin hydrochloride belongs to the glycopeptide antibiotic class and works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial death. It is commonly prescribed for severe infections such as bloodstream infections, endocarditis, bone infections, and hospital-acquired pneumonia. Due to its potency, this IV infusion is typically administered in hospitals or controlled healthcare environments.
Key Features & Benefits:
- Broad-spectrum activity against gram-positive bacteria
- Effective against resistant infections like MRSA
- Sterile vial packaging for safe intravenous use
- Trusted choice in critical care and hospital treatments
Usage & Safety:
Ancolase-1000 should only be administered by healthcare professionals. Dosage depends on the patient’s condition, kidney function, and the severity of infection. Monitoring is essential to avoid side effects such as nephrotoxicity or infusion-related reactions.
Conclusion:
With its proven efficacy and reliable formulation, Ancolase-1000 stands as a critical solution for life-threatening infections. Always use under strict medical guidance to ensure optimal therapeutic outcomes and patient safety.
